The Role of Kisspeptin in the Pathogenesis of Pregnancy Complications: A Narrative Review

Magdalena Szydełko-Gorzkowicz; Elżbieta Poniedziałek-Czajkowska; Radzisław Mierzyński; Maciej Sotowski; Bożena Leszczyńska-Gorzelak

The Role of Kisspeptin in the Pathogenesis of Pregnancy Complications: A Narrative Review

2022

Magdalena Szydełko-Gorzkowicz | Elżbieta Poniedziałek-Czajkowska | Radzisław Mierzyński | Maciej Sotowski | Bożena Leszczyńska-Gorzelak

Kisspeptins are the family of neuropeptide products of the KISS-1 gene that exert the biological action by binding with the G-protein coupled receptor 54 (GPR54), also known as the KISS-1 receptor. The kisspeptin level dramatically increases during pregnancy, and the placenta is supposed to be its primary source. The role of kisspeptin has already been widely studied in hypogonadotropic hypogonadism, fertility, puberty disorders, and insulin resistance-related conditions, including type 2 diabetes mellitus, polycystic ovary syndrome, and obesity. Gestational diabetes mellitus (GDM), preeclampsia (PE), preterm birth, fetal growth restriction (FGR), or spontaneous abortion affected 2 to 20% of pregnancies worldwide. Their occurrence is associated with numerous short and long-term consequences for mothers and newborns; hence, novel, non-invasive predictors of their development are intensively investigated. The study aims to present a comprehensive review emphasizing the role of kisspeptin in the most common pregnancy-related disorders and neonatal outcomes. The decreased level of kisspeptin is observed in women with GDM, FGR, and a high risk of spontaneous abortion. Nevertheless, there are still many inconsistencies in kisspeptin concentration in pregnancies with preterm birth or PE. Further research is needed to determine the usefulness of kisspeptin as an early marker of gestational and neonatal complications.

اظهر المزيد [+]